Skip to main content

Table 3 Artificial intelligence-assisted design of PEG-modified MLP liposomes incorporating varying hydrogenated soy phosphatidylcholine (HSPC), dioleoylphosphatidylglycerol (DOPG), and cholesterol (CH) ratios

From: Combination therapy with lipid prodrug liposomes reshapes disease-associated neutrophils to promote the cancer-immunity cycle

Number

Proportion

Number

Proportion

Number

Proportion

1

50: 50: 0

13

25: 70: 5

25

40: 40: 20

2

65: 35: 0

14

55: 40: 5

26

55: 25: 20

3

35: 65: 0

15

40: 55: 5

27

25: 55: 20

4

50: 0: 50

16

70: 20: 10

28

30: 30: 40

5

65: 0: 35

17

20: 70: 10

29

35: 20: 45

6

35: 0: 65

18

45: 45: 10

30

20: 35: 45

7

0: 50: 50

19

35: 35: 30

31

15: 15: 70

8

0: 65: 35

20

50: 20: 30

32

10: 30: 60

9

0: 35: 65

21

20: 50: 30

33

30: 10: 60

10

85: 10: 5

22

40: 10: 50

34

20: 20: 60

11

10: 85: 5

23

30: 20: 50

35

10: 40: 50

12

70: 25: 5

24

25: 25: 50

36

20: 30: 50

  1. HSPC: DOPG: CH = A: B: C